Skip to main content

PSIL · AdvisorShares Psychedelics ETF ETF

AdvisorShares Trust

SEC fund profile
$24.86 +1.10% At close · Sep 4
Net assets $44,429,797
Holdings32
1 month
-2.16%
Year to date
+44.79%
52-week range
$15.64–$27.02
30-session avg volume
36,331

Market performance

Adjusted close · up to five years

Since Sep 2021

Fund profile

Structure
Open-end / ETF
SEC series
S000072085
Report date
Jun 30, 2026
Holdings coverage
Full reported portfolio

Portfolio concentration

Top 10 holdings69.23%

Calculated only when the SEC filing is stored with complete portfolio coverage.

Asset allocation

EC95.93%
STIV7.07%

Country allocation

US57.74%
CA25.20%
GB11.45%
IE8.61%

Portfolio holdings

Latest linked SEC Form NPORT-P report.

Export CSV
HoldingValueWeight
DEFINIUM THERAPEUTICS INC$5,709,76212.85%
COMPASS PATHWAYS PLC$5,089,00511.45%
ATAIBECKLEY INC$4,652,84110.47%
RELMADA THERAPEUTICS INC$3,037,1956.84%
NRX PHARMACEUTICALS INC$2,695,3846.07%
NEUROCRINE BIOSCIENCES INC$1,947,0854.38%
CYBIN INC$1,934,8204.35%
GH RESEARCH PLC$1,915,6574.31%
ALKERMES PLC$1,909,1694.30%
ALTO NEUROSCIENCE INC$1,867,0404.20%
ABBVIE INC$1,841,5024.14%
BLACKROCK TREASURY TRUST$1,763,3573.97%
BRIGHT MINDS BIOSCIENCES INC$1,704,0353.84%
JOHNSON & JOHNSON$1,602,0433.61%
DREY INST PREF GOV MM-M$1,378,9573.10%
SUPERNUS PHARMACEUTICALS INC$1,284,5132.89%
NEUPHORIA THERAPEUTICS INC$1,105,2122.49%
NEURONETICS INC$965,6342.17%
QUANTUM BIOPHARMA LTD$736,9021.66%
OPTIMI HEALTH CORP$523,2211.18%
PASITHEA THERAPEUTICS CORP$483,2131.09%
SILO PHARMA INC$469,3641.06%
PSYENCE BIOMEDICAL LTD$373,8830.84%
INCANNEX HEALTHCARE INC$228,8640.52%
NUMINUS WELLNESS INC$209,0830.47%
IGC PHARMA INC$184,5470.42%
VISTAGEN THERAPEUTICS INC$99,1330.22%
ENVERIC BIOSCIENCES INC$48,8750.11%
CLEARMIND MEDICINE INC$2,5720.01%
SAGE THERAPEUTICS INC$00.00%
QUANTUM BIOPHARMA$00.00%
UNBUZZD WELLNESS INC$00.00%